Warren Buffett said that "people who use EBITDA are either trying to con you or they’re conning themselves".
Let's look instead at cold hard cash flow:
Receipts: $3,585K
Payments: -$4,144K
Tax benefit: $609K (This may stop)
Capex: -34K (This can't stop)
R&D: -940K (This can't stop)
Net cash bleed before financing: -$924K. It's much worse than last year.
Good luck relying on a UK expansion (will be much harder) when they haven't proven to generate sufficient cash at home yet.
Warren Buffett said that "people who use EBITDA are either...
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.6¢ |
Change
-0.001(5.88%) |
Mkt cap ! $10.81M | |||
| Open | High | Low | Value | Volume |
| 1.8¢ | 1.8¢ | 1.6¢ | $16.01K | 972.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 224715 | 1.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.8¢ | 292756 | 4 |
View Market Depth
| Last trade - 14.04pm 18/11/2024 (20 minute delay) ? |
| SPA (ASX) Chart |